/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
With a market cap of $45.2 billion, Edwards Lifesciences Corporation (EW) is a global leader in innovative products and technologies for treating advanced cardiovascular diseases. The company specializes in transcatheter and surgical heart valve solutions, as well as critical care monitoring systems, serving patients across the United States, Europe, Japan, and worldwide.
Shares of the Irvine, California-based company have underperformed the broader market over the past 52 weeks. EW stock has increased 17.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 18.7%. Moreover, shares of the company have risen 4.9% on a YTD basis, compared to SPX's 9.7% return.
